Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
pLADD in metastatic colorectal cancer
NCT03189030Phase 1Terminated
- Sponsor
- Aduro Biotech, Inc.
- Start
- May 2017
- Primary completion
- Oct 2019
- Modality
- Microbiome Therapeutics, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of pLADD in metastatic colorectal cancer (mCRC), sponsored by Aduro Biotech, Inc. Primary endpoint: Incidence of Treatment-Emergent Adverse Events. Started May 2017; status: terminated.
02
Drugs
pLADD
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT03189030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03189030.